Evidence map›Paper›PMID 22621783›Full record

ArticleAmerican journal of physiology. Cell physiology2012

Cyclic AMP-Rap1A signaling activates RhoA to induce α(2c)-adrenoceptor translocation to the cell surface of microvascular smooth muscle cells.

Selvi C Jeyaraj, Nicholas T Unger, Ali H Eid, Srabani Mitra, N Paul El-Dahdah, Lawrence A Quilliam, Nicholas A Flavahan, Maqsood A Chotani

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Inhibiting Intracellular αInternational journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. The Role of Epac in Cancer Progression.International journal of molecular sciences · 2020
    Review
  15. EPAC in Vascular Smooth Muscle Cells.International journal of molecular sciences · 2020
    Review
  16. Review
  17. Estrogen and Bisphenol A in Hypertension.Current hypertension reports · 2020
    Review
  18. 7-Biomolecules · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Selvi C JeyarajCenter for Cardiovascular and Pulmonary Research, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, USA.
Nicholas T Unger
Ali H Eid
Srabani Mitra
N Paul El-Dahdah
Lawrence A Quilliam
Nicholas A Flavahan
Maqsood A Chotani
Nationwide Children's Hospital · USLung Institute · USIndiana University – Purdue University Indianapolis · USJohns Hopkins Medicine · USQatar University · QA

Funding

Training in Congenital and Acquired Heart DiseaseT32HL098039 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GARG, VIDU, MOHLER, PETER J. · 2009 to 2019
$2.5M
Mechanism of vascular alpha2C-adrenoceptor mobilizationR21HL088087 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI CHOTANI, MAQSOOD A. · 2008 to 2009
$405k
NHLBI NIH HHS 1R21HL088087-01NHLBI NIH HHS R21 HL088087NHLBI NIH HHS T32HL098039-01
6 · The paper itself

Abstract

Intracellular signaling by the second messenger cyclic AMP (cAMP) activates the Ras-related small GTPase Rap1 through the guanine exchange factor Epac. This activation leads to effector protein interactions, activation, and biological responses in the vasculature, including vasorelaxation. In vascular smooth muscle cells derived from human dermal arterioles (microVSM), Rap1 selectively regulates expression of G protein-coupled α(2C)-adrenoceptors (α(2C)-ARs) through JNK-c-jun nuclear signaling. The α(2C)-ARs are generally retained in the trans-Golgi compartment and mobilize to the cell surface and elicit vasoconstriction in response to cellular stress. The present study used human microVSM to examine the role of Rap1 in receptor localization. Complementary approaches included murine microVSM derived from tail arteries of C57BL6 mice that express functional α(2C)-ARs and mice deficient in Rap1A (Rap1A-null). In human microVSM, increasing intracellular cAMP by direct activation of adenylyl cyclase by forskolin (10 μM) or selectively activating Epac-Rap signaling by the cAMP analog 8-pCPT-2'-O-Me-cAMP (100 μM) activated RhoA, increased α(2C)-AR expression, and reorganized the actin cytoskeleton, increasing F-actin. The α(2C)-ARs mobilized from the perinuclear region to intracellular filamentous structures and to the plasma membrane. Similar results were obtained in murine wild-type microVSM, coupling Rap1-Rho-actin dynamics to receptor relocalization. This signaling was impaired in Rap1A-null murine microVSM and was rescued by delivery of constitutively active (CA) mutant of Rap1A. When tested in heterologous HEK293 cells, Rap1A-CA or Rho-kinase (ROCK-CA) caused translocation of functional α(2C)-ARs to the cell surface (~4- to 6-fold increase, respectively). Together, these studies support vascular bed-specific physiological role of Rap1 and suggest a role in vasoconstriction in microVSM.

Indexed as

AnimalsArteriolesCells, CulturedCyclic AMPGene Expression RegulationHumansMiceMice, KnockoutMyocytes, Smooth MuscleProtein BindingProtein Transportrap1 GTP-Binding ProteinsReceptors, Adrenergic, alpha-2rhoA GTP-Binding ProteinCyclic AMPrap1 GTP-Binding ProteinsReceptors, Adrenergic, alpha-2rhoA GTP-Binding Protein

Identifiers

PMID22621783
PMCPMC3468345
OpenAlexW1983136275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.